The study showed a trend toward improved survival with adjuvant chemotherapy in patients with low CDX2 expression, although this trend did not achieve statistical significance ( p = 0.113).
← all excerpts
Molecular Biology of Cancer-Interplay of Malignant Cells with Emerging Therapies.
1
—
—